Bavarian Nordic receives UK MHRA marketing authorization for chikungunya vaccine, Vimkunya for persons aged 12 and older
Bavarian Nordic A/S, a global vaccine company, announced that the UK Medicines and Healthcare products Regulatory Agency (MHRA) has granted marketing authorization in the United Kingdom (UK) for Vimkunya (recombinant, adsorbed) for active immunization …